041960.KQ
Komipharm International Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 9,380.00
+8.06%Margins
Gross margin
33.3%
EBITDA margin
7.7%
EBIT margin
1.9%
Net margin
-4.9%
FCF margin
-5.5%
-3.6%
Return on equity
-1.9%
Return on assets
0.9%
Return on invested capital
0.39x
Asset turnover
KRW 983.6M
Cash from operations
KRW 370
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026